Competitive: Worldwide Clinical Trials - APAC: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
Vous n'êtes pas connecté
Satellos Biosciences (TSX:MSCL) reveals it has received approval to begin a Phase 1 clinical trial in Australia for SAT-3247.
Competitive: Worldwide Clinical Trials - APAC: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
IQVIA, formerly Quintiles and IMS Health, Inc.,is an American multinational company serving the combined industries of health information technology...
Nxera Pharma Co., Ltd.(formerly known as Sosei Group or Sosei Heptares), announces that it will receive a US$ 35 million payment from Neurocrine...
Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim,...
MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.
HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...
A team led by research scientists from the Indiana University School of Medicine and Regenstrief Institute has received funding expected to total...
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
Competitive: Worldwide Clinical Trials - APAC: Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the...